Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pfizer Inc. buy gerihouse

Pfizer Inc.
Start price
€30.10
28.10.15 / 50%
Target price
€33.21
03.06.16
Performance (%)
1.22%
End price
€29.72
03.06.16
Summary
This prediction ended on 03.06.16 with a price of €29.72. The BUY prediction by gerihouse finished with a performance of 1.22%. gerihouse has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Pfizer Inc. -2.727% -2.727% -32.311% -25.859%
iShares Core DAX® 2.594% -1.158% 14.782% 16.813%
iShares Nasdaq 100 3.553% -1.727% 43.265% 44.227%
iShares Nikkei 225® 0.687% -8.354% 18.454% 1.361%
iShares S&P 500 2.209% -0.942% 31.361% 42.812%

According to gerihouse what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Future proof or reliable business model
Innovative
High dividend yield expected
Good rating
Cons

Comments by gerihouse for this prediction

In the thread Pfizer Inc. diskutieren
Prediction Buy
Perf. (%) 1.22%
Target price 35.000
Change
Ends at 03.06.16

optimistisch

gerihouse stimmt am 28.10.2015 dem Sell-Crowdsentiment mit dem Kursziel 29.1€ nicht zu.


Trotz Einbußen beim Umsatz wegen des starken Dollars zeigen sich die Pharmakonzerne Pfizer und Merck nun optimistisch.

Bei Pfizer war es sogar die zweite Erhöhung binnen zwei Monaten. Der New Yorker Konzern profitierte von kräftiger Nachfrage nach seinen Impfstoffen. Das Unternehmen verdiente zwar mit 2,13 Milliarden Dollar gut eine halbe Milliarde Dollar weniger als im Vorjahr, der bereinigte Gewinn lag jedoch höher als von Experten erwartet. Die Aktie legte im vorbörslichen Handel zu.

gerihouse 
0
Report Share
28.10.15
Prediction Buy
Perf. (%) 1.22%
Target price 35.000
Change
Ends at 03.06.16

(Vom Mitglied beendet)

gerihouse 
0
Report Share
03.06.16

Current prediction by gerihouse for Pfizer Inc.

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.25
27.07.23
€40.00
27.07.24
-24.06%
26.04.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
27.07.23 50%

Stopped prediction by gerihouse for Pfizer Inc.

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€46.84
04.04.22
€55.00
04.04.23
2.48%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
04.04.22 80%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.26
23.03.22
€55.00
23.03.23
-3.61%
02.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
23.03.22 90%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.21
08.07.21
€55.00
08.07.22
29.12%
18.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
08.07.21 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
04.08.20
€38.00
04.11.21
0.31%
13.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
04.08.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.80
18.03.20
€37.95
07.05.20
23.39%
07.05.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
18.03.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€36.41
20.02.19
€42.79
24.05.19
-0.28%
24.05.19

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.90
27.10.14
€25.62
12.12.14
11.39%
12.12.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.31
22.04.14
€28.46
22.09.14
6.63%
22.09.14

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€21.43
29.05.13
€23.72
14.11.13
6.46%
14.11.13

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%